AngioDynamics, Inc. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease)
AngioDynamics, Inc. (ANGO) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) of $40.00 thousand for the 3-month period ending 2025-02-28, per its 10-Q filed 2025-04-02.
Financial Statements › Notes › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease · last filed 2025-04-02
- AngioDynamics, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for the quarter ending 2025-02-28 was $40.00K, a 64.29% decline year-over-year.
- AngioDynamics, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for the quarter ending 2024-11-30 was $156.00K, a 29.41% decline year-over-year.
- AngioDynamics, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for the quarter ending 2024-08-31 was $76.00K.
- AngioDynamics, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for the quarter ending 2024-02-29 was $112.00K.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) 9 month |
|---|---|---|---|
| 2025-02-28 | $40.00K 10-Q · filed 2025-04-02 | $196.00K derived: sum of 2 quarters · filed 2025-04-02 | $272.00K 10-Q · filed 2025-04-02 |
| 2024-11-30 | $156.00K 10-Q · filed 2025-01-08 | $232.00K 10-Q · filed 2025-01-08 | |
| 2024-08-31 | $76.00K 10-Q · filed 2024-10-03 | ||
| 2024-02-29 | $112.00K 10-Q · filed 2024-04-09 | $333.00K derived: sum of 2 quarters · filed 2024-04-09 | $203.00K 10-Q · filed 2024-04-09 |
| 2023-11-30 | $221.00K 10-Q · filed 2024-01-08 | $91.00K 10-Q · filed 2024-01-08 | |
| 2023-08-31 | -$130.00K 10-Q · filed 2023-10-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |